Prothena Corp Public (PRTA) EBT Margin Growth (3y) (2015 - 2026)
Prothena Corp Public (PRTA) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 235,894.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235,894.00 |
| Dec 31, 2025 | -10.28 Mn |
| Sep 30, 2025 | 166,318.00 |
| Jun 30, 2025 | 141,303.00 |
| Mar 31, 2025 | 112,218.00 |
| Dec 31, 2024 | 2,121.00 |
| Sep 30, 2024 | -624,712.00 |
| Jun 30, 2024 | 268.00 |
| Mar 31, 2024 | -12.88 Mn |
| Dec 31, 2023 | -1.39 Mn |
| Sep 30, 2023 | 1.96 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 847,740.00 |
| Sep 30, 2022 | 606,691.00 |
| Jun 30, 2022 | 631,566.00 |
| Mar 31, 2022 | 781,892.00 |
| Dec 31, 2021 | 846,992.00 |
| Sep 30, 2021 | 933,219.00 |
| Jun 30, 2021 | 2.22 Mn |